Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

111In-DTPA-D-Phe1-Octreotide Binding and Somatostatin Receptor Subtypes in Thyroid Tumors

Eva B. Forssell-Aronsson, Ola Nilsson, Sven Anders Benjegård, Lars Kölby, Peter Bernhardt, Johan Mölne, S. Hossein Hashemi, Bo Wängberg, Lars-Erik Tisell and Håkan Ahlman
Journal of Nuclear Medicine April 2000, 41 (4) 636-642;
Eva B. Forssell-Aronsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ola Nilsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Anders Benjegård
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Kölby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bernhardt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Mölne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Hossein Hashemi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Wängberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars-Erik Tisell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Håkan Ahlman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 4 636-642
PubMed 
10768564

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT© 2000 by the Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 74 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2001 to April 2025

AbstractFullPdf
Mar 2001300
Apr 2001500
May 2001400
Jun 2001200
Jul 2001200
Aug 2001100
Oct 2001504
Dec 2001301
Jan 2002300
Feb 2002402
Mar 2002103
Apr 2002401
May 2002200
Jun 2002400
Jul 2002502
Aug 2002300
Sep 2002201
Oct 2002100
Nov 2002101
Dec 2002303
Feb 2003100
Apr 2003101
May 2003101
Jun 2003300
Jul 20031403
Aug 2003801
Sep 20031202
Oct 20031206
Nov 20031900
Dec 2003603
Jan 20041000
Feb 2004900
Mar 2004702
Apr 2004803
May 2004601
Jun 20041602
Jul 20041801
Aug 20041008
Sep 2004702
Oct 2004602
Nov 20041002
Dec 2004804
Jan 20052305
Feb 2005904
Mar 2005904
Apr 2005401
May 20051101
Jul 2005100
Aug 2005500
Sep 2005602
Oct 2005704
Nov 20051404
Dec 20051002
Jan 2006502
Feb 2006401
Mar 2006104
Apr 20061000
May 2006502
Jun 2006808
Jul 2006600
Aug 2006601
Sep 2006404
Oct 2006506
Nov 2006401
Jan 2007104
Feb 2007507
Mar 200710020
Apr 20076013
May 2007003
Jun 2007806
Jul 2007407
Aug 2007403
Sep 20073011
Oct 2007403
Nov 20078012
Dec 2007509
Jan 2008708
Feb 2008307
Mar 20085016
Apr 20086015
May 200814017
Jun 200817018
Jul 20086012
Aug 20081205
Sep 200816010
Oct 20081107
Nov 20085012
Dec 2008501
Jan 2009906
Feb 2009404
Mar 20091007
Apr 2009607
May 2009608
Jun 2009604
Jul 2009207
Aug 2009503
Sep 20095014
Oct 2009909
Nov 200917016
Dec 2009707
Jan 2010407
Feb 2010606
Mar 2010403
Apr 2010708
May 20101906
Jun 2010109
Jul 2010907
Aug 2010405
Sep 20103011
Oct 2010706
Nov 20106010
Dec 2010906
Jan 20115016
Feb 2011709
Mar 2011608
Apr 20115018
May 20112011
Jun 20110013
Jul 20110011
Aug 20110015
Sep 20110012
Oct 2011008
Nov 20110012
Dec 2011008
Jan 20120017
Feb 20120011
Mar 20120011
Apr 2012008
May 2012008
Jun 2012009
Jul 2012006
Aug 2012009
Sep 2012005
Oct 2012009
Nov 2012006
Dec 2012009
Jan 2013008
Feb 2013008
Mar 2013003
Apr 2013005
May 20130015
Jun 2013004
Jul 20130010
Aug 2013005
Sep 2013004
Oct 2013004
Nov 2013002
Dec 2013002
Jan 2014005
Feb 2014005
Mar 2014006
Apr 2014005
May 2014005
Jun 2014002
Jul 20140014
Aug 2014007
Sep 2014007
Oct 2014004
Nov 2014005
Dec 2014004
Jan 2015005
Feb 2015007
Mar 2015004
Apr 2015002
May 2015008
Jun 2015002
Jul 20150013
Aug 2015005
Sep 20150011
Oct 20150011
Nov 20150010
Dec 2015005
Jan 20160015
Feb 20160015
Mar 2016007
Apr 2016009
May 20160014
Jun 2016007
Jul 20160011
Aug 20160022
Sep 20160012
Oct 2016006
Nov 2016006
Dec 2016001
Jan 2017006
Feb 2017002
Mar 2017006
Apr 2017004
May 2017001
Jun 2017004
Jul 2017006
Aug 20170013
Sep 2017008
Oct 2017004
Nov 2017003
Dec 2017003
Jan 2018003
Feb 2018002
Mar 2018005
Apr 2018009
May 2018007
Jun 2018004
Jul 2018003
Aug 2018001
Sep 2018002
Oct 2018004
Nov 2018005
Dec 2018005
Jan 2019001
Feb 2019003
Mar 2019002
Apr 2019004
May 2019006
Jun 2019005
Jul 20190010
Aug 2019002
Sep 2019002
Oct 2019004
Nov 2019004
Dec 20190011
Jan 2020005
Feb 2020009
Mar 2020009
Apr 2020001
May 2020003
Jun 2020005
Jul 2020003
Aug 2020003
Sep 2020005
Oct 2020001
Nov 2020004
Dec 2020003
Jan 2021006
Feb 2021105
Mar 2021002
Apr 2021009
May 2021007
Jun 2021200
Jul 2021009
Aug 2021109
Sep 2021001
Oct 2021004
Nov 2021009
Dec 2021108
Jan 2022004
Feb 2022105
Mar 2022102
Apr 2022102
May 2022206
Jun 2022004
Jul 2022105
Aug 2022004
Sep 2022003
Oct 2022003
Nov 2022305
Dec 2022003
Jan 2023103
Feb 2023702
Mar 2023008
Apr 2023400
May 2023005
Jun 2023003
Jul 2023008
Aug 2023306
Sep 2023001
Oct 2023009
Nov 2023003
Dec 2023002
Jan 2024103
Feb 2024001
Mar 2024002
Apr 2024209
May 20241011
Jun 2024003
Jul 2024006
Aug 20240014
Sep 2024203
Oct 20241014
Nov 20240012
Dec 2024006
Jan 20251010
Feb 2025007
Mar 20251013
Apr 20250025
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 41, Issue 4
April 1, 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
111In-DTPA-D-Phe1-Octreotide Binding and Somatostatin Receptor Subtypes in Thyroid Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
111In-DTPA-D-Phe1-Octreotide Binding and Somatostatin Receptor Subtypes in Thyroid Tumors
Eva B. Forssell-Aronsson, Ola Nilsson, Sven Anders Benjegård, Lars Kölby, Peter Bernhardt, Johan Mölne, S. Hossein Hashemi, Bo Wängberg, Lars-Erik Tisell, Håkan Ahlman
Journal of Nuclear Medicine Apr 2000, 41 (4) 636-642;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
111In-DTPA-D-Phe1-Octreotide Binding and Somatostatin Receptor Subtypes in Thyroid Tumors
Eva B. Forssell-Aronsson, Ola Nilsson, Sven Anders Benjegård, Lars Kölby, Peter Bernhardt, Johan Mölne, S. Hossein Hashemi, Bo Wängberg, Lars-Erik Tisell, Håkan Ahlman
Journal of Nuclear Medicine Apr 2000, 41 (4) 636-642;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin
  • Preclinical Evaluation of New and Highly Potent Analogues of Octreotide for Predictive Imaging and Targeted Radiotherapy
  • Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
  • Clinical Impact of Somatostatin Receptor Scintigraphy in the Management of Paragangliomas of the Head and Neck
  • 18F-FDG PET of Patients with Hurthle Cell Carcinoma
  • Crucial Role for Somatostatin Receptor Subtype 2 in Determining the Uptake of [111In-DTPA-D-Phe1]Octreotide in Somatostatin Receptor-Positive Organs
  • An Intrapatient Comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire